Art

J-GLOBAL ID：202102291113844251   Reference number：21A3293979

Targeting Akt in cancer for precision therapy

精密治療のための癌におけるAktの標的化【JST・京大機械翻訳】

Author (6)： Hui Hua, (State Key Laboratory of Biotherapy, Laboratory of Stem Cell Biology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China) ,  Hongying Zhang, (State Key Laboratory of Biotherapy, Laboratory of Oncogene, Cancer Center, West China Hospital, Sichuan University, Chengdu, China) ,  Jingzhu Chen, (State Key Laboratory of Biotherapy, Laboratory of Oncogene, Cancer Center, West China Hospital, Sichuan University, Chengdu, China) ,  Jiao Wang, (School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China) ,  Jieya Liu, (State Key Laboratory of Biotherapy, Laboratory of Oncogene, Cancer Center, West China Hospital, Sichuan University, Chengdu, China) ,  Yangfu Jiang, (State Key Laboratory of Biotherapy, Laboratory of Oncogene, Cancer Center, West China Hospital, Sichuan University, Chengdu, China)
Material： Journal of Hematology & Oncology (Web)
Volume： 14  Issue： 1  Page： 1-25  Publication year： 2021 
JST Material Number： U7517A  ISSN： 1756-8722  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Biomarkers-guided precision th...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A3293979&from=J-GLOBAL&jstjournalNo=U7517A") }}

Thesaurus term： antitumor drug ,  tumor ,  tumor cell ,  drug resistance ,  genome ,  clinical trial ,  *targeting ,  biomarker ,  serine-threonine kinase ,  molecular target therapy ,  Individualized Medicine
Semi thesaurus term： 腫瘍成長 ,  *Akt/蛋白質キナーゼB ,  癌治療 ,  分子標的 , 【Automatic Indexing@JST】

Author keywords (6)： Akt ,  Biomarker ,  Cancer ,  Cell signaling ,  Precision therapy ,  Targeted therapy

JST classification (5)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Basic research of antitumor(=antineoplastic)drugs  (GW16010A) ,  Basic research of enzyme preparations and enzyme inhibitor preparations  (GW21010W)

Reference (200)：

• Cancers (Basel); Pursuing precision: Receptor tyrosine kinase inhibitors for treatment of pediatric solid tumors; AJ Bellantoni, LM Wagner; 13; 2021; 3531; 10.3390/cancers13143531; citation_id=CR1
• J Hematol Oncol; Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma; Y Qian, Y Gong, Z Fan, G Luo, Q Huang, S Deng; 13; 2020; 130; 10.1186/s13045-020-00958-3; citation_id=CR2
• J Hematol Oncol; MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer; Q Wang, S Yang, K Wang, SY Sun; 12; 2019; 63; 10.1186/s13045-019-0759-9; citation_id=CR3
• Eur J Pharmacol; Molecular targeted therapy: Treating cancer with specificity; YT Lee, YJ Tan, CE Oon; 834; 2018; 188-196; 10.1016/j.ejphar.2018.07.034; citation_id=CR4
• J Hematol Oncol; BCMA-targeted immunotherapy for multiple myeloma; B Yu, T Jiang, D Liu; 13; 2020; 125; 10.1186/s13045-020-00962-7; citation_id=CR5

Terms in the title (4)： 治療 ,  癌 ,  Akt ,  標的化